Home › Cancer (all types) › NCT05582551

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Who can join

Ages 7 to 17 · All sexes

Inclusion Criteria:

* Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age)
* Treatment including chemotherapy and/or radiation therapy
* Completion of all cancer therapy for at least 6 months and less than 2 years
* Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
* Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
* English speaking

Exclusion Criteria:

* Undergoing active cancer treatment
* Patient under the care of the Late Effects Program at St. Louis Children's Hospital
* Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
* Parents and/or patient illiteracy
* No contact with treatment team in the past two years
* In foster care or without a legal guardian

About the study

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

What is being tested

• Highlighting Patients at Risk for Sensory Screening (HPARSS) (other)

Sponsor: Washington University School of Medicine · Participants: 146 · Started: Aug 2, 2023

Contact the study team

• Robert J Hayashi, M.D. · Phone: 314-454-6018

Official record on ClinicalTrials.gov — NCT05582551

Locations in the U.S.

Conditions

• Cancer (all types)
• Hearing Loss
• Peripheral Nerve Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.